Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy

MT Milano, EE Vokes, JK Salama, KM Stenson… - International Journal of …, 2005 - Elsevier
PURPOSE: We previously demonstrated the efficacy of concurrent gemcitabine, paclitaxel,
and 5-fluorouracil in conjunction with twice-daily (1.5-Gy) radiotherapy delivered on …
被引用次数：54 相关文章

Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy

MT Milano, EE Vokes, JK Salama… - International …, 2005 - scholars.northwestern.edu
Purpose: We previously demonstrated the efficacy of concurrent gemcitabine, paclitaxel, and
5-fluorouracil in conjunction with twice-daily (1.5-Gy) radiotherapy delivered on alternating …

Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.

MT Milano, EE Vokes, JK Salama… - … Journal of Radiation …, 2005 - europepmc.org
Purpose We previously demonstrated the efficacy of concurrent gemcitabine, paclitaxel, and
5-fluorouracil in conjunction with twice-daily (1.5-Gy) radiotherapy delivered on alternating …

Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy

MT Milano, EE Vokes, JK Salama, KM Stenson… - International Journal of …, 2005 - infona.pl
We previously demonstrated the efficacy of concurrent gemcitabine, paclitaxel, and 5-
fluorouracil in conjunction with twice-daily (1.5-Gy) radiotherapy delivered on alternating …

Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy

MT Milano, EE Vokes, JK Salama… - International Journal of …, 2005 - redjournal.org
Purpose We previously demonstrated the efficacy of concurrent gemcitabine, paclitaxel, and
5-fluorouracil in conjunction with twice-daily (1.5-Gy) radiotherapy delivered on alternating …
[PDF] academia.edu

[PDF][PDF] TWICE-DAILY REIRRADIATION FOR RECURRENT AND SECOND PRIMARY HEAD-AND-NECK CANCER WITH GEMCITABINE, PACLITAXEL, AND 5 …

MT MILANO, MD PH, EE VOKES… - Int. J. Radiation …, 2005 - academia.edu
Purpose: We previously demonstrated the efficacy of concurrent gemcitabine, paclitaxel, and
5-fluorouracil in conjunction with twice-daily (1.5-Gy) radiotherapy delivered on alternating …

Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy

MT Milano, EE Vokes, JK Salama… - International Journal of …, 2005 - inis.iaea.org
[en] Purpose: We previously demonstrated the efficacy of concurrent gemcitabine, paclitaxel,
and 5-fluorouracil in conjunction with twice-daily (1.5-Gy) radiotherapy delivered on …

Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy

MT Milano, EE Vokes, JK Salama… - … journal of radiation …, 2005 - pubmed.ncbi.nlm.nih.gov
Purpose We previously demonstrated the efficacy of concurrent gemcitabine, paclitaxel, and
5-fluorouracil in conjunction with twice-daily (1.5-Gy) radiotherapy delivered on alternating …
[PDF] academia.edu

[PDF][PDF] TWICE-DAILY REIRRADIATION FOR RECURRENT AND SECOND PRIMARY HEAD-AND-NECK CANCER WITH GEMCITABINE, PACLITAXEL, AND 5 …

MT MILANO, MD PH, EE VOKES… - Int. J. Radiation …, 2005 - academia.edu
Purpose: We previously demonstrated the efficacy of concurrent gemcitabine, paclitaxel, and
5-fluorouracil in conjunction with twice-daily (1.5-Gy) radiotherapy delivered on alternating …

[引用][C] Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy

MT MILANO, EE VOKES, JK SALAMA… - International journal of …, 2005 - Elsevier